Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 68071-1915 by Nucare Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 1915 3 K41

pdp - 68071 1915 3 K41

NuCare Pharmaceuticals, Inc. has a product named Atorvastatin Calcium with a strength of 20mg. It comes in a bottle of 30 tablets with Lot # 000000 and a National Drug Code (NDC) of 68071-1915-03. Each tablet is film-coated and contains atorvastatin calcium equivalent to 20mg atorvastatin. The expiration date is not available. The tablets are white and round with "P" engraved on them. People who experience side effects due to taking the drug can contact their doctor or report it to FDA via a phone number. It is advisable to keep the medicine out of children's reach and store it in controlled temperature between 68-77°F.*

Chemical Structure - atorvastatin calcium tablets 1

Chemical Structure - atorvastatin calcium tablets 1

Figure 1 - atorvastatin calcium tablets 2

Figure 1 - atorvastatin calcium tablets 2

The text shows a graph or a table displaying the cumulative incidence percentage over a period of 35 years with the HR (hazard ratio) and p-value mentioned. The values of cumulative incidence percentage at years 1, 5, 10, and 15 are 404%, 30%, 15%, and not available for the remaining years. The hazard ratio of 0.64 indicates a lower risk of occurrence of the event being studied. The p-value of 0.0005 suggests that the result is statistically significant.*

Figure 2 - atorvastatin calcium tablets 3

Figure 2 - atorvastatin calcium tablets 3

The text describes a graph or a chart that shows the cumulative hazard percentage in relation to the time taken to reach the first primary endpoint through 4 years of follow up. The hazard ratio is given as 0.63 along with the confidence interval and p-value. The data seems to be a result of some sort of medical or scientific study.*

Figure 3 - atorvastatin calcium tablets 4

Figure 3 - atorvastatin calcium tablets 4

The text provides information on the percentage of subjects who experienced events under Atorvastatin 10 mg and 80 mg at various time points. The HR (Hazard Ratio) value and P-value are also mentioned. Therefore, it appears to be a clinical study data table.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.